Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Goodwill & Intangibles (2020 - 2023)

Scynexis' (SCYX) quarterly Goodwill & Intangibles came in at $103000.0 in Q3 2023, down 86.62% on a YoY basis from $770000.0 in Q3 2022, and down 50.0% quarter-over-quarter from $206000.0 in Q2 2023.

Analysis

Scynexis (SCYX) Goodwill & Intangibles (2020 - 2023) Analysis & Trends

Scynexis (SCYX) has reported Goodwill & Intangibles for 4 consecutive years, with $103000.0 the latest figure, recorded in Q3 2023.

  • For the quarter ending Q3 2023, Goodwill & Intangibles fell 86.62% year-over-year to $103000.0; the trailing twelve-month figure through Sep 2023 stood at $103000.0 (down 86.62% YoY), and the FY2022 full-year result was $408000.0, down 61.36% from the prior year.
  • Goodwill & Intangibles fell to $103000.0 in Q3 2023 per SCYX's latest filing, from $206000.0 in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $1.3 million in Q4 2020 and bottomed at $103000.0 in Q3 2023.
  • Historically, Goodwill & Intangibles has averaged $671333.3 across 4 years, with a median of $671000.0 in 2021.
  • The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles jumped 154.23% in 2022, then tumbled 86.62% in 2023.
  • Over 4 years, Goodwill & Intangibles stood at $1.3 million in 2020, then decreased by 17.63% to $1.1 million in 2021, then sank by 61.36% to $408000.0 in 2022, then sank by 74.75% to $103000.0 in 2023.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $103000.0, $206000.0, and $309000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 103,000.00
Jun 30, 2023 206,000.00
Mar 31, 2023 309,000.00
Dec 31, 2022 408,000.00
Sep 30, 2022 770,000.00
Jun 30, 2022 866,000.00
Mar 31, 2022 961,000.00
Dec 31, 2021 1.06 Mn
Sep 30, 2021 1.15 Mn
Jun 30, 2021 572,000.00
Mar 31, 2021 378,000.00
Dec 31, 2020 1.28 Mn